Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: a phase II trial of oral estramustine and oral etoposide.
about
Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: a phase II trial of oral estramustine and oral etoposide.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Chemotherapy in patients with ...... tramustine and oral etoposide.
@en
Chemotherapy in patients with ...... tramustine and oral etoposide.
@nl
type
label
Chemotherapy in patients with ...... tramustine and oral etoposide.
@en
Chemotherapy in patients with ...... tramustine and oral etoposide.
@nl
prefLabel
Chemotherapy in patients with ...... tramustine and oral etoposide.
@en
Chemotherapy in patients with ...... tramustine and oral etoposide.
@nl
P2860
P1433
P1476
Chemotherapy in patients with ...... tramustine and oral etoposide.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20010601)91:11<2175::AID-CNCR1246>3.0.CO;2-D
P407
P577
2001-06-01T00:00:00Z